Efficacy and safety of teicoplanin in infections caused by methicillin-resistant Staphylococcus aureus

J Antimicrob Chemother. 1996 Jan;37(1):197-200. doi: 10.1093/jac/37.1.197.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Humans
  • Methicillin Resistance*
  • Middle Aged
  • Skin Diseases, Infectious / drug therapy*
  • Soft Tissue Infections / drug therapy*
  • Staphylococcal Infections / drug therapy*
  • Teicoplanin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Teicoplanin